Full text is available at the source.
Abstract
A new functional assay may accurately predict immune checkpoint inhibitor response.
- Most patients treated with immune checkpoint inhibitors do not respond to the treatment.
- There is a significant demand for predictive biomarkers to identify which patients will benefit from immune checkpoint inhibitors.
- The reported functional assay could provide insights into the likelihood of treatment response.
Simplified